Literature DB >> 19932968

Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model.

Sarjubhai A Patel1, Trideep Rajale, Erin O'Brien, David J Burkhart, Jared K Nelson, Brendan Twamley, Alex Blumenfeld, Monika I Szabon-Watola, John M Gerdes, Richard J Bridges, Nicholas R Natale.   

Abstract

Analogues of amino methylisoxazole propionic acid (AMPA), were prepared from a common intermediate 12, including lipophilic analogues using lateral metalation and electrophilic quenching, and were evaluated at System xc-. Both the 5-naphthylethyl-(16) and 5-naphthylmethoxymethyl-(17) analogues adopt an E-conformation in the solid state, yet while the former has robust binding at System xc-, the latter is virtually devoid of activity. The most potent analogues were amino acid naphthyl-ACPA 7g, and hydrazone carboxylic acid, 11e Y=Y'=3,5-(CF(3))(2), which both inhibited glutamate uptake by the System xc- transporter with comparable potency to the endogenous substrate cystine, whereas in contrast the closed isoxazolo[3,4-d] pyridazinones 13 have significantly lower activity. A preliminary pharmacophore model has been constructed to provide insight into the analogue structure-activity relationships. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19932968      PMCID: PMC2967674          DOI: 10.1016/j.bmc.2009.11.001

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  36 in total

1.  Neuroadaptations in cystine-glutamate exchange underlie cocaine relapse.

Authors:  David A Baker; Krista McFarland; Russell W Lake; Hui Shen; Xing-Chun Tang; Shigenobu Toda; Peter W Kalivas
Journal:  Nat Neurosci       Date:  2003-07       Impact factor: 24.884

2.  Compromised glutamate transport in human glioma cells: reduction-mislocalization of sodium-dependent glutamate transporters and enhanced activity of cystine-glutamate exchange.

Authors:  Z C Ye; J D Rothstein; H Sontheimer
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

3.  The origin and neuronal function of in vivo nonsynaptic glutamate.

Authors:  David A Baker; Zheng-Xiong Xi; Hui Shen; Chad J Swanson; Peter W Kalivas
Journal:  J Neurosci       Date:  2002-10-15       Impact factor: 6.167

4.  Isoxazolo-[3,4-d]-pyridazin-7-(6H)-ones and their corresponding 4,5-disubstituted-3-(2H)-pyridazinone analogues as new substrates for alpha1-adrenoceptor selective antagonists: synthesis, modeling, and binding studies.

Authors:  F Montesano; D Barlocco; V Dal Piaz; A Leonardi; E Poggesi; F Fanelli; P G De Benedetti
Journal:  Bioorg Med Chem       Date:  1998-07       Impact factor: 3.641

5.  Differentiation of substrate and non-substrate inhibitors of transport system xc(-): an obligate exchanger of L-glutamate and L-cystine.

Authors:  Sarjubhai A Patel; Brady A Warren; Joseph F Rhoderick; Richard J Bridges
Journal:  Neuropharmacology       Date:  2004-02       Impact factor: 5.250

6.  Exchange of cystine and glutamate across plasma membrane of human fibroblasts.

Authors:  S Bannai
Journal:  J Biol Chem       Date:  1986-02-15       Impact factor: 5.157

7.  Comparison of Na+-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1).

Authors:  L A Dowd; A J Coyle; J D Rothstein; D B Pritchett; M B Robinson
Journal:  Mol Pharmacol       Date:  1996-03       Impact factor: 4.436

Review 8.  A role for glutamate in growth and invasion of primary brain tumors.

Authors:  Harald Sontheimer
Journal:  J Neurochem       Date:  2008-02-14       Impact factor: 5.372

9.  The Lathyrus excitotoxin beta-N-oxalyl-L-alpha,beta-diaminopropionic acid is a substrate of the L-cystine/L-glutamate exchanger system xc-.

Authors:  Brady A Warren; Sarjubhai A Patel; Peter B Nunn; Richard J Bridges
Journal:  Toxicol Appl Pharmacol       Date:  2004-10-15       Impact factor: 4.219

10.  Synthesis and preliminary pharmacological evaluation of novel derivatives of L-beta-threo-benzylaspartate as inhibitors of the neuronal glutamate transporter EAAT3.

Authors:  Terri L Mavencamp; Joseph F Rhoderick; Richard J Bridges; C Sean Esslinger
Journal:  Bioorg Med Chem       Date:  2008-07-08       Impact factor: 3.641

View more
  13 in total

Review 1.  The cystine/glutamate antiporter system x(c)(-) in health and disease: from molecular mechanisms to novel therapeutic opportunities.

Authors:  Jan Lewerenz; Sandra J Hewett; Ying Huang; Maria Lambros; Peter W Gout; Peter W Kalivas; Ann Massie; Ilse Smolders; Axel Methner; Mathias Pergande; Sylvia B Smith; Vadivel Ganapathy; Pamela Maher
Journal:  Antioxid Redox Signal       Date:  2012-08-03       Impact factor: 8.401

2.  Sulfasalazine for brain cancer fits.

Authors:  Harald Sontheimer; Richard J Bridges
Journal:  Expert Opin Investig Drugs       Date:  2012-03-12       Impact factor: 6.206

3.  System xc⁻ cystine/glutamate antiporter: an update on molecular pharmacology and roles within the CNS.

Authors:  Richard J Bridges; Nicholas R Natale; Sarjubhai A Patel
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

4.  Use of the hydantoin isostere to produce inhibitors showing selectivity toward the vesicular glutamate transporter versus the obligate exchange transporter system x(c)(-).

Authors:  S Kaleem Ahmed; Jean-Louis G Etoga; Sarjubhai A Patel; Richard J Bridges; Charles M Thompson
Journal:  Bioorg Med Chem Lett       Date:  2011-05-14       Impact factor: 2.823

5.  Suzuki-Miyaura Cross-Coupling of Benzylic Bromides Under Microwave Conditions.

Authors:  Steven W McDaniel; Charles M Keyari; Kevin C Rider; Nicholas R Natale; Philippe Diaz
Journal:  Tetrahedron Lett       Date:  2011-10-26       Impact factor: 2.415

Review 6.  Thinking outside the cleft to understand synaptic activity: contribution of the cystine-glutamate antiporter (System xc-) to normal and pathological glutamatergic signaling.

Authors:  Richard Bridges; Victoria Lutgen; Doug Lobner; David A Baker
Journal:  Pharmacol Rev       Date:  2012-07       Impact factor: 25.468

7.  Microwave accelerated synthesis of isoxazole hydrazide inhibitors of the system xc- transporter: Initial homology model.

Authors:  Afnan A Matti; Joseph Mirzaei; John Rudolph; Stephen A Smith; Jayme L Newell; Sarjubhai A Patel; Michael R Braden; Richard J Bridges; Nicholas R Natale
Journal:  Bioorg Med Chem Lett       Date:  2013-08-27       Impact factor: 2.823

Review 8.  Main path and byways: non-vesicular glutamate release by system xc(-) as an important modifier of glutamatergic neurotransmission.

Authors:  Ann Massie; Séverine Boillée; Sandra Hewett; Lori Knackstedt; Jan Lewerenz
Journal:  J Neurochem       Date:  2015-09-29       Impact factor: 5.372

Review 9.  Heteromeric Amino Acid Transporters in Brain: from Physiology to Pathology.

Authors:  Ekaitz Errasti-Murugarren; Manuel Palacín
Journal:  Neurochem Res       Date:  2021-02-19       Impact factor: 3.996

10.  Ethyl 5-(4-amino-phen-yl)isoxazole-3-carboxyl-ate.

Authors:  Jun-Tao Zhao; Jing-Jing Qi; You-Jun Zhou; Jia-Guo Lv; Ju Zhu
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2012-03-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.